U.S. markets closed

Soleno Therapeutics, Inc. (SLNO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.1200-0.0900 (-7.44%)
At close: 4:00PM EDT

1.1400 +0.02 (1.79%)
After hours: 7:59PM EDT

Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 4/12/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 0.44
52-Week Change 3-61.09%
S&P500 52-Week Change 349.51%
52 Week High 34.3900
52 Week Low 31.1101
50-Day Moving Average 31.7565
200-Day Moving Average 31.9978

Share Statistics

Avg Vol (3 month) 31.84M
Avg Vol (10 day) 31.78M
Shares Outstanding 579.62M
Implied Shares Outstanding 6N/A
Float 42.65M
% Held by Insiders 116.32%
% Held by Institutions 158.88%
Shares Short (Mar 14, 2021) 41.73M
Short Ratio (Mar 14, 2021) 40.65
Short % of Float (Mar 14, 2021) 42.77%
Short % of Shares Outstanding (Mar 14, 2021) 42.17%
Shares Short (prior month Feb 11, 2021) 4774.31k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 05, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Oct 05, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-38.71%
Return on Equity (ttm)-81.46%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-24.64M
Diluted EPS (ttm)-0.3930
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)49.22M
Total Cash Per Share (mrq)0.62
Total Debt (mrq)147k
Total Debt/Equity (mrq)0.32
Current Ratio (mrq)5.83
Book Value Per Share (mrq)0.57

Cash Flow Statement

Operating Cash Flow (ttm)-25.22M
Levered Free Cash Flow (ttm)-13.3M